UK Seeks AI Rules to Spur Health-Care Overhaul, Protect Patients

The United Kingdom is advancing its efforts to establish regulations for artificial intelligence within the healthcare sector. This initiative includes the formation of a national commission aimed at attracting investment in health technology while maximizing the benefits of the AI revolution. Comprising a diverse group of doctors, academics, and regulatory specialists, the commission will engage with patients and major tech firms like Microsoft and Google to develop actionable recommendations. Lawrence Tallon, the CEO of the Medicines and Healthcare Products Regulatory Agency (MHRA), emphasized the urgency of updating current medical device regulations to align with AI advancements. He noted, "Unless we can update that regulatory framework for AI, we will ultimately be slowing up the potential application." Led by renowned AI healthcare expert Alastair Denniston, with Patient Safety Commissioner Henrietta Hughes serving as deputy chair, the commission plans to provide feedback to the MHRA and contribute to a regulatory framework expected to be published by 2026. As AI continues to be integrated into healthcare — from tools that assist in interpreting radiology images to adaptive cardiac devices — concerns have arisen regarding the outdated regulations established over 20 years ago. The World Health Organization has flagged various risks associated with AI technology, including unethical data practices and cybersecurity threats. As countries worldwide grapple with how to effectively balance AI's promise with its potential dangers, the European Union has proposed the AI Act, which includes guidelines for medical devices. However, this approach has faced criticism from tech companies that believe it may be overly restrictive. Tallon clarified that the UK does not intend to replicate the EU's regulatory model but aims for a framework that is both clear and practical. He stated, "The problem we have at the moment is because we have a lack of clarity in the global regulation of AI, it’s quite hard for different parties to know what they need to do and what to expect. I want us to bring clarity and confidence to that overall framework." Some elements of this new regulation will likely require legislative approval from Parliament. As competition for AI investments heats up, with the UK government recently securing multi-billion-dollar deals with tech giants like Microsoft and OpenAI, the proposed regulations may raise concerns among tech companies about increased oversight. Nonetheless, Tallon argued that effective regulation can be beneficial, asserting that a lack of oversight is not always the best approach. He remarked, "We must ensure that the AI used in healthcare has the confidence and trust of both clinicians and patients. Firms desire predictable and proportionate regulation, rather than none at all. That’s the sweet spot we are looking to find."